TSE:BLU BELLUS Health (BLU) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free BLU Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$19.48▼C$19.4852-Week Range N/AVolume28,666 shsAverage Volume59,471 shsMarket CapitalizationC$2.47 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider Trades Get BELLUS Health alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About BELLUS Health Stock (TSE:BLU)BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Read More Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here BLU Stock News HeadlinesMarch 19, 2024 | americanbankingnews.comBELLUS Health (TSE:BLU) Shares Cross Below 50 Day Moving Average of $19.48February 7, 2024 | msn.comIs Blue Cross Blue Shield your health plan? Dignity Health providers are no longer in your networkMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 6, 2024 | msn.comBlue Cross Blue Shield no longer has a contract with Dignity Health. Here's what we knowFebruary 3, 2024 | morningstar.comMind Medicine Inc Ordinary Shares MNMDDecember 22, 2023 | sfgate.comAdventist Health Hospitals To Once Again Accept Blue Shield Of California PatientsDecember 5, 2023 | msn.comAlgernon Pharmaceuticals: Investigating a Novel Therapy for Stroke Patients Using the Psychedelic Drug N,N-Dimethyltryptamine (DMT)October 30, 2023 | benzinga.comBellus Beauty: The New England Beauty Brand Revolutionizing SkincareMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.August 10, 2023 | finance.yahoo.comCOMMODORE CAPITAL LP Acquires New Stake in Vistagen Therapeutics IncApril 27, 2023 | theglobeandmail.comClosing Bell: Bellus Health Inc down on Thursday (BLU)April 24, 2023 | theglobeandmail.comClosing Bell: Bellus Health Inc down on Monday (BLU)April 21, 2023 | theglobeandmail.comClosing Bell: Bellus Health Inc up on Friday (BLU)April 20, 2023 | benzinga.comBELLUS Health Stock (NASDAQ:BLU), Short Interest ReportApril 18, 2023 | markets.businessinsider.comCanadian Market Modestly Higher; Bellus Health Soars On Acquisition NewsApril 18, 2023 | benzinga.comMoore Kuehn Encourages RXDX, STSA, CHRA, and BLU Investors to Contact Law FirmApril 18, 2023 | finance.yahoo.comGSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS HealthApril 18, 2023 | theglobeandmail.comGSK plans to buy Canada-based drug developer Bellus Health for $2-billionApril 18, 2023 | proactiveinvestors.comGSK pays £1.6bn for Canada's Bellus HealthApril 18, 2023 | msn.comGSK bets $2 billion on Bellus cough drug to soothe pipeline fearsApril 18, 2023 | msn.comBellus surges ~100% after GSK reaches deal to acquire cough drugmaker for ~$2BApril 18, 2023 | msn.comGSK to Acquire Bellus Health for $2 BillionApril 18, 2023 | msn.comGSK to acquire Canada’s Bellus Health for $14.75 per shareApril 6, 2023 | theglobeandmail.comClosing Bell: Bellus Health Inc down on Wednesday (BLU)March 6, 2023 | msn.com4 Biotech Stocks That Could Break Through the MarketMarch 1, 2023 | finance.yahoo.comBELLUS Health to Participate in the Cowen 43rd Annual Health Care ConferenceFebruary 1, 2023 | markets.businessinsider.comTSX Recovers After Mid-session Setback, Ends Just Marginally DownSee More Headlines Receive BLU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:BLU CUSIPN/A CIKN/A Webwww.bellushealth.com Phone+1-450-6804500FaxN/AEmployees74Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-86,790,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-26.76% Return on Assets-16.70% Debt Debt-to-Equity Ratio0.32 Current Ratio33.42 Quick Ratio16.40 Sales & Book Value Annual SalesC$16,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.67 Book ValueC$2.91 per share Price / BookN/AMiscellaneous Outstanding Shares126,810,000Free FloatN/AMarket CapC$2.47 billion OptionableNot Optionable Beta-0.28 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Roberto Francesco Bellini (Age 43)Pres, CEO & Director Comp: $790.35kMr. Ramzi Benamar (Age 50)Chief Financial Officer Comp: $650.48kDr. Andreas Orfanos FFPM (Age 64)M.B.B.Ch, MBA, Chief Operating Officer Comp: $417.58kDr. Denis Garceau Ph.D. (Age 66)Chief Scientific Officer Comp: $496.56kDr. Catherine M. Bonuccelli M.D. (Age 65)Chief Medical Officer Comp: $741.66kMr. Daniel MatthewsDirector of Investor Relations & CommunicationsMr. Tony Matzouranis (Age 50)Chief Bus. Officer Mr. Sebastien Roy (Age 47)Corp. Sec. More ExecutivesKey CompetitorsTrillium TherapeuticsTSE:TRILConcordia InternationalTSE:CXRTilray BrandsTSE:TLRYCronos GroupTSE:CRONdentalcorpTSE:DNTLView All Competitors BLU Stock Analysis - Frequently Asked Questions Should I buy or sell BELLUS Health stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BELLUS Health in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BLU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BLU, but not buy additional shares or sell existing shares. View BLU analyst ratings or view top-rated stocks. What other stocks do shareholders of BELLUS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Exxon Mobil (XOM), Bombardier (BDRBF), AbbVie (ABBV), Energy Transfer (ET), General Electric (GE), Coca-Cola (KO), Alexion Pharmaceuticals (ALXN), Advanced Micro Devices (AMD), Boeing (BA) and Walt Disney (DIS). How do I buy shares of BELLUS Health? Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:BLU) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.